How routine pharmacovigilance failed to identify finasteride's persistent sexual side effects

Andrology. 2022 Feb;10(2):207-208. doi: 10.1111/andr.13122. Epub 2021 Nov 9.

Author

Michael S Irwig^{1

2}

Affiliations

¹ Division of Endocrinology, Beth Israel Deaconess Medical Center, Boston, USA.
² Harvard Medical School, Boston, USA.

PMID: 34713622
DOI: 10.1111/andr.13122

No abstract available

Keywords: erectile dysfunction; finasteride; pharmacovigilance.

MeSH terms

Finasteride / adverse effects*
Genital Diseases, Male / chemically induced*
Humans
Male
Pharmacovigilance*
Sexual Dysfunction, Physiological / chemically induced*
Syndrome
Urological Agents / adverse effects*

Substances

Urological Agents
Finasteride